Target intelligence / Profile preview

Emopamil-binding protein-like (EBPL)

Target
EBPL
Molecular classification
Other (predicted to be distantly related to isomerase enzymes but does not possess characterized enzymatic activity)
01

Overview

Emopamil-binding protein-like (EBPL) is a human protein encoded by the EBPL gene on chromosome 13q14.2. It shares moderate sequence homology with emopamil-binding protein (EBP), a known sterol delta8-delta7 isomerase involved in cholesterol biosynthesis. Unlike EBP, EBPL lacks detectable sterol isomerase and sigma-ligand binding activity, as confirmed by heterologous expression studies and functional analyses. Most residues required for isomerase activity are conserved in EBPL, but key differences preclude catalytic function. EBPL is ubiquitously expressed, with highest mRNA levels in liver, lung, and kidney. Frameshift mutations in EBPL have been detected in microsatellite unstable tumors; resultant neopeptides are rapidly degraded via the proteasome, suggesting the protein is tightly regulated. The physiological function of EBPL remains unknown, and it has not been linked to specific diseases or therapeutic agents. The protein is classified as "other" in molecular terms due to its unclear function and lack of canonical receptor, enzyme, transporter, or transcription factor activity.

Other names
EBPLEBRPERPEmopamil-binding-related proteinDelta8-delta7 sterol isomerase-related proteinemopamil-binding protein-likeemopamil binding related protein
02

Biological functions

Unknown (no confirmed enzymatic activity, possibly involved in uncharacterized cellular pathways)
03

Disease associations

Other (rare frameshift mutations in EBPL have been identified in microsatellite-unstable tumors, but no established disease association)

Beyond the preview

Go deeper on Emopamil-binding protein-like (EBPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emopamil-binding protein-like (EBPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call